Literature DB >> 6950024

[Clinical, genetic and pathological aspects of Machado-Joseph disease].

P Coutinho, J Sequeiros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6950024

Source DB:  PubMed          Journal:  J Genet Hum        ISSN： 0021-7743


× No keyword cloud information.
  9 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Different origins of mutations at the Machado-Joseph locus (MJD1)

Authors:  P Iughetti; M Zatz; M R Bueno; S K Marie
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

3.  Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease.

Authors:  Sara Duarte-Silva; Andreia Neves-Carvalho; Carina Soares-Cunha; Andreia Teixeira-Castro; Pedro Oliveira; Anabela Silva-Fernandes; Patrícia Maciel
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

4.  Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.

Authors:  Maria do Carmo Costa; Naila S Ashraf; Svetlana Fischer; Yemen Yang; Emily Schapka; Gnanada Joshi; Thomas J McQuade; Rahil M Dharia; Mark Dulchavsky; Michelle Ouyang; David Cook; Duxin Sun; Martha J Larsen; Jason E Gestwicki; Sokol V Todi; Magdalena I Ivanova; Henry L Paulson
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

5.  Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado-Joseph Disease.

Authors:  Ana Bela Campos; Sara Duarte-Silva; Bruno Fernandes; Bárbara Coimbra; Jonas Campos; Daniela Monteiro-Fernandes; Andreia Teixeira-Castro; António Francisco Ambrósio; Patrícia Maciel
Journal:  Cells       Date:  2022-06-25       Impact factor: 7.666

6.  Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus.

Authors:  E C Twist; L K Casaubon; M H Ruttledge; V S Rao; P M Macleod; J Radvany; Z Zhao; R N Rosenberg; L A Farrer; G A Rouleau
Journal:  J Med Genet       Date:  1995-01       Impact factor: 6.318

7.  Strabismus and Micro-Opsoclonus in Machado-Joseph Disease.

Authors:  Fatema F Ghasia; George Wilmot; Anwar Ahmed; Aasef G Shaikh
Journal:  Cerebellum       Date:  2016-08       Impact factor: 3.847

8.  Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Katiuska Luna-Cancalon; Svetlana Fischer; Naila S Ashraf; Michelle Ouyang; Rahil M Dharia; Lucas Martin-Fishman; Yemen Yang; Vikram G Shakkottai; Beverly L Davidson; Edgardo Rodríguez-Lebrón; Henry L Paulson
Journal:  Mol Ther       Date:  2013-06-14       Impact factor: 11.454

9.  Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease.

Authors:  Naila S Ashraf; Sara Duarte-Silva; Emily D Shaw; Patrícia Maciel; Henry L Paulson; Andreia Teixeira-Castro; Maria do Carmo Costa
Journal:  Mol Neurobiol       Date:  2018-09-04       Impact factor: 5.590
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.